Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study.

摘要

The analysis of self-monitoring of blood glucose (SMBG) in the community-based observational Fremantle Diabetes Study (1) becomes even more interesting when combined with three other studies of SMBG in type 2 diabetes: the Italian Qualita ed Esito in Dia-betologia (QuED) Project (2), analyses of the Kaiser Permanente Northern California Medical Care Program (3), and the German ROSSO Study (4). All four studies concur that patients using SMBG are younger at diagnosis by 3-4 years (1,2,4). Patients present with higher A1C (mean +0.9%) (4). Even during continuous use of SMBG, mean A1C levels are slightly higher (difference 0.2-0.3%) (2-4) or slightly lower (-0.3%) (1) than in patients not using SMBG (mean of all four studies +0.2-0.3%).